Myriad Genetics | MYGN - Trade Debtors


Myriad Genetics reported $115.3M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Agilent USD 1.5B 23M Mar/2026
Becton, Dickinson and Co. USD 2.36B 159M Jun/2026
Bio-Rad Laboratories USD 441.8M 15.6M Jun/2026
Bruker USD 545.9M 3.2M Jun/2026
Danaher USD 4.96B 205M Jun/2026
Illumina USD 764M 26M Jun/2026
J&J USD 22.54B 1.21B Mar/2026
Mettler Toledo International USD 731.48M 23.27M Jun/2026
Myriad Genetics USD 115.3M 2.7M Dec/2025
OraSure Technologies USD 22.2M 2.1M Dec/2025
Pacific Biosciences Of California USD 35.45M 4.83M Dec/2025
Quest Diagnostics USD 1.67B 79M Jun/2026
Quidel USD 352M 7.9M Jun/2026
Repligen USD 157.71M 6.16M Jun/2026
Revvity USD 709.18M 17.79M Jun/2026
Standard Biotools USD 41.64M 28.21M Mar/2026
Thermo Fisher Scientific USD 9.45B 247M Jun/2026
Veracyte USD 54.18M 4.06M Jun/2026
Waters USD 1.99B 228M Jun/2026